Viewing Study NCT02447393


Ignite Creation Date: 2025-12-25 @ 1:10 AM
Ignite Modification Date: 2025-12-27 @ 3:07 AM
Study NCT ID: NCT02447393
Status: COMPLETED
Last Update Posted: 2017-08-03
First Post: 2011-06-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Study of Levocetirizine
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module